In the future, comprehensive clinical studies are required to further validate the correlation between gastric cancer prognosis and GJB2 expression.Our data also showed that high expression of GJB2 was associated with worse prognosis outcomes in patients with CESC, KIRC, OV, GBM, and SARC. Here, GJB2 is linked to glioblastoma.